MNTA: One last thought on MNTA's odds. TEVA is a large company with some 200 applications (and probably 10 lawyers for each.) They also own proprietary compounds such as Copaxone.
On the other hand, Momenta is small, nimble and has been almost singularly focused on Generic Lovenox for years. They were also spawned out of the MIT research juggernaut.
Having the backing of Novartis is rather telling, imo.
I like their odds.
"If we don't succeed, we run the risk of failure."
-Dan Quayle